Results 1 to 10 of about 197,741 (365)

Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK

open access: yesLancet Regional Health - Europe, The, 2022
Background The continued success of the COVID-19 vaccination programme in the UK will depend on widespread uptake of booster vaccines. However, there is evidence of hesitancy and unwillingness to receive the booster vaccine, even in fully vaccinated ...
Elise Paul, Daisy Fancourt
exaly   +2 more sources

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

open access: yesNew England Journal of Medicine, 2021
Background On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least ...
Y. Bar-On   +10 more
semanticscholar   +1 more source

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)

open access: yesLife, 2022
Background: The coronavirus disease 2019 (COVID-19) pandemic is currently ongoing, and there have been significant efforts in the development of COVID-19 vaccines.
Yuriko Terayama   +10 more
doaj   +1 more source

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

open access: yesThe Lancet, 2021
Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4–12 weeks.
M. Voysey   +499 more
semanticscholar   +1 more source

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response

open access: yesVaccines, 2022
The long-term effect of protection by two doses of SARS-CoV-2 vaccination in patients receiving chronic intermittent hemodialysis (CIHD) is an urging question.
Sammy Patyna   +12 more
doaj   +1 more source

Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration

open access: yesDiagnostics, 2022
Coronavirus disease 2019 (COVID-19) was declared a pandemic due to its rapid spread worldwide, and its vaccination campaign is considered one of the most historic public hygiene measures in modern medicine.
Federica Zoccali   +9 more
doaj   +1 more source

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

open access: yesNew England Journal of Medicine, 2022
Background The safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known. Methods In this ongoing, phase 2–3 study, we compared the 50-μg bivalent vaccine mRNA-1273.214 (25 μg each of ancestral Wuhan-Hu-1 ...
S. Chalkias   +18 more
semanticscholar   +1 more source

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

open access: yesVaccines, 2022
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 vaccine has been used in many countries, but it is still unable to control the ...
Sitthichai Kanokudom   +14 more
doaj   +1 more source

Homologous and Heterologous Covid-19 Booster Vaccinations

open access: yesNew England Journal of Medicine, 2022
Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring.
R. Atmar   +37 more
semanticscholar   +1 more source

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis

open access: yesFrontiers in Public Health, 2022
BackgroundCOVID-19 is a respiratory illness caused by SARS-CoV-2. The most recent variant is Omicron (line B.1.1.529), which was first identified in South Africa in November 2021. The concern with this variant is the ineffectiveness of vaccines currently
Yuntao Zou   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy